Literature DB >> 10619493

The prognostic role of vessel productive changes and vessel density in oligodendroglioma.

D Schiffer1, I Bosone, A Dutto, N Di Vito, A Chiò.   

Abstract

The recognition of the anaplastic variant of oligodendroglioma is difficult, since it is not easy to identify histological prognostic factors. Among the latter, vascular productive changes have been inconsistently put in relation with survival. In 95 cases of operated oligodendrogliomas, endothelial cell hyperplasia, microvascular proliferations and capillary density were studied by histological and immunohistochemical methods. Capillary density was evaluated on CD31-stained sections by a grid of 100 squares placed in the ocular of the microscope. Statistical analysis was performed in order to compare these parameters with survival. A nodular growth pattern was observed more frequently among tumor grades 3-4 than among tumor grades 1-2. Endothelial cell hyperplasia was more frequent in nodular growth pattern, but it did not correlate with survival. The highest capillary density was found in nodular growth pattern, but it did not correlate with survival as well. Microvascular proliferations correlated with survival only in univariate, but not in multivariate analysis. Age, extent of surgical removal, year of surgery, post-operative Karnofsky score and MIB-1 LI remained associated with survival, as observed in a previous study.

Entities:  

Mesh:

Year:  1999        PMID: 10619493     DOI: 10.1023/a:1006206920822

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  34 in total

1.  Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis.

Authors:  S Heegaard; H M Sommer; H Broholm; O Broendstrup
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

2.  The vascular response to tumor infiltration in malignant gliomas. Morphometric and reconstruction study.

Authors:  D Schiffer; A Chiò; M T Giordana; A Mauro; A Migheli; M C Vigliani
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.

Authors:  C Daumas-Duport; M L Tucker; H Kolles; P Cervera; F Beuvon; P Varlet; N Udo; M Koziak; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

4.  Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases.

Authors:  C Daumas-Duport; P Varlet; M L Tucker; F Beuvon; P Cervera; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

5.  Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study.

Authors:  P Wesseling; R O Schlingemann; F J Rietveld; M Link; P C Burger; D J Ruiter
Journal:  J Neuropathol Exp Neurol       Date:  1995-05       Impact factor: 3.685

6.  Oligodendroglioma: the Rotterdam-Dijkzigt experience.

Authors:  J M Kros; H Pieterman; C G van Eden; C J Avezaat
Journal:  Neurosurgery       Date:  1994-06       Impact factor: 4.654

7.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

8.  The treatment of anaplastic oligodendrogliomas and mixed gliomas.

Authors:  A P Kyritsis; W K Yung; J Bruner; M J Gleason; V A Levin
Journal:  Neurosurgery       Date:  1993-03       Impact factor: 4.654

9.  Oligodendroglioma. Histologic evaluation and prognosis.

Authors:  S J Mørk; T B Halvorsen; K F Lindegaard; G E Eide
Journal:  J Neuropathol Exp Neurol       Date:  1986-01       Impact factor: 3.685

10.  Oligodendrogliomas: the Mayo Clinic experience.

Authors:  E G Shaw; B W Scheithauer; J R O'Fallon; H D Tazelaar; D H Davis
Journal:  J Neurosurg       Date:  1992-03       Impact factor: 5.115

View more
  11 in total

1.  The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.

Authors:  A Korshunov; A Golanov
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.

Authors:  Sarah F Smith; Judy M Simpson; Janice A Brewer; Lali H S Sekhon; Michael T Biggs; Raymond J Cook; Nicholas S Little
Journal:  J Neurooncol       Date:  2006-06-23       Impact factor: 4.130

3.  Differential diagnosis of oligodendroglial and astrocytic tumors using imaging results: the added value of perfusion MR imaging.

Authors:  Hyun Jung Yoon; Kook Jin Ahn; Song Lee; Jin Hee Jang; Hyun Seok Choi; So Lyung Jung; Bum Soo Kim; Shin Soo Jeun; Yong Kil Hong
Journal:  Neuroradiology       Date:  2017-05-26       Impact factor: 2.804

4.  Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.

Authors:  Kevin Leu; Garrett A Ott; Albert Lai; Phioanh L Nghiemphu; Whitney B Pope; William H Yong; Linda M Liau; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2017-05-25       Impact factor: 4.130

5.  Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging.

Authors:  Soonmee Cha; Tarik Tihan; Forrest Crawford; Nancy J Fischbein; Susan Chang; Andrew Bollen; Sarah J Nelson; Michael Prados; Mitchel S Berger; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

6.  Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.

Authors:  Wei Bian; Inas S Khayal; Janine M Lupo; Colleen McGue; Scott Vandenberg; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Sarah J Nelson
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

7.  Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.

Authors:  T Kato; J Shinoda; N Nakayama; K Miwa; A Okumura; H Yano; S Yoshimura; T Maruyama; Y Muragaki; T Iwama
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-03       Impact factor: 3.825

8.  Immunohistochemical markers for prognosis of oligodendroglial neoplasms.

Authors:  Andrey Korshunov; Andrey Golanov; Regina Sycheva
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

9.  Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer.

Authors:  L A Akslen; O Straume; S Geisler; T Sørlie; J-T Chi; T Aas; A-L Børresen-Dale; P E Lønning
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640

10.  Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

Authors:  Michael D Jenkinson; Trevor S Smith; Kathy A Joyce; Diane Fildes; John Broome; Daniel G du Plessis; Brian Haylock; David J Husband; Peter C Warnke; Carol Walker
Journal:  Neuroradiology       Date:  2006-08-26       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.